Review traces a DNA repair pathway component's evolving biology and translational potential as a therapeutic target in diverse cancers.
Key Takeaways
- Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital
- China, Changsha, China The final, formatted version of the article will be published soon
- You have multiple emails registered with Frontiers: You don't have a Frontiers account ?